Cardiovascular risks associated with smoking: a review for clinicians

Area of Science:

• Cardiovascular Medicine
• Public Health
• Smoking Cessation

Background:

• Cardiovascular consequences of cigarette smoking are often underestimated compared to respiratory effects.
• Smoking is a major risk factor for numerous cardiovascular diseases and adverse outcomes.
• Physicians play a crucial role in guiding patients to quit smoking.

Purpose of the Study:

• To highlight the significant cardiovascular risks associated with cigarette smoking.
• To emphasize the importance and cost-effectiveness of smoking cessation interventions.
• To confirm the safety and tolerability of pharmacotherapies in cardiovascular patients.

Main Methods:

• Review of established medical literature on smoking and cardiovascular disease.
• Analysis of the efficacy and cost-effectiveness of smoking cessation pharmacotherapies.
• Evaluation of safety data for nicotine replacement therapy and bupropion in cardiac populations.

Main Results:

• Smoking is linked to sudden death, myocardial infarction, coronary heart disease, and cerebrovascular disease.
• It worsens outcomes post-angioplasty/bypass surgery and increases risks for aortic aneurysm, peripheral vascular disease, hypertension complications, and impotence.
• Nicotine replacement and bupropion are well-tolerated in patients with cardiovascular disease.

Conclusions:

• Physicians must actively encourage and support all smoking patients in cessation efforts.
• Pharmacotherapy for smoking cessation is a highly cost-effective healthcare intervention.
• Dependent smokers should be offered evidence-based cessation treatments, including pharmacotherapy, which is safe for cardiovascular patients.